Dashenlin (603233): The national layout has basically been completed, and the stage of deepening market cultivation has begun
Dashanlin (603233): Stores maintain high growth and upward inventory turnover
Daisenlin (603233): The growth rate of the franchise business is impressive, and the nationwide layout of stores continues to advance
Daisenbayashi (603233): Short-term performance is under pressure to strengthen the national layout
Dashenlin (603233): Revenue growth is slowing down, gross margin is being phased under pressure
Daishanlin (603233): 2024H1 profit temporarily declined due to declining spending power and more new stores in the cultivation period
Dashenlin (603233): Deeply involved in South China and the continuous development of the country's leading chain of high-quality pharmacies
Daisenlin (603233): Continued expansion of stores and accelerated development of franchise business
Dashanlin (603233): 2024Q1 performance is under short-term pressure, and the nationwide layout of stores is still progressing
Dashanlin (603233): Direct franchise advantages highlight the continuous increase in the number of stores
Dashanlin (603233): Diversified store expansion towards national performance is disrupted by the short-term pace of store construction
Daisenbayashi (603233): Performance is in line with expectations, self-construction accelerates quarter by quarter
Dashanlin (603233): Store expansion accelerates upward inventory turnover
Daishanlin (603233): Continued store expansion and short-term pressure on performance under high base
Daisenlin (603233): Revenue is growing rapidly, profits are under pressure in the short term
Dashenlin (603233): The leading pharmacy chain in South China accelerates the national layout and can be expected to grow at a high rate
Daishanlin (603233): Self-built store expansion accelerates franchise and distribution business expansion
Daisenbayashi (603233): The results of the 23-year quarterly report were in line with expectations
Daxanlin (603233) 2023 Third Quarter Report Review: Steady growth in performance, impressive growth in franchise and distribution business
Daxanlin (603233): Balancing Strong and Weak Regions and Expanding Franchise Business Rapidly
No Data
No Data